Jasper Therapeutics's total assets for Q4 2024 were $79.90M, a decrease of -19.63% from the previous quarter. JSPR total liabilities were $18.23M for the fiscal quarter, a 15.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.